Merck (MRK) call put ratio 1 call to 5.9 puts
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/5/2026
- Nasdaq notches record high close as investors focus on earnings
- Oil slips on rising Mideast crude exports, G7 stocks release
- Intel stock slides as TSMC explores Terafab tie-up, analyst flags share losses
- Schneider Electric to acquire PTC for $22.6 billion in all-cash deal
- Five things to watch in markets in the week ahead
- Citi cuts investment banking analyst program to two years - Bloomberg
- Alaska LNG shipping savings justifies billions in investment, developer says
- Paramount Skydance to close WBD deal, change ticker to SKYD
- Nasdaq notches record high close as investors focus on earnings
- This multi-trillion stock is "cheap and getting cheaper": Morgan Stanley
CFRA Upgrades Merck (MRK) to Buy (midday)
November 19, 2024 4:27 PM ESTCFRA upgraded Merck (NYSE: MRK) from Hold to Buy with a price target of $108.00.
For an analyst ratings summary and ratings history on Merck click here. For more ratings news on Merck click here.
Shares of Merck closed at $96.56 yesterday.
... MoreJPMorgan Reiterates Overweight Rating on Merck (MRK)
November 19, 2024 8:44 AM ESTJPMorgan analyst Chris Schott reiterated an Overweight rating and $145.00 price target on Merck (NYSE: MRK).
The analyst comments "This morning, MRK announced that the Ph3 trial for the subQ formulation of Keytruda (with berahyaluronidase alfa) met its dual primary PK endpoints, which we see as removing tail risk to the story as we think about the longer-term... More



